glp-1 receptor agonist with dpp-4 inhibitor combination not recommended agonists vs. inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Combination therapy with once-weekly glucagon

Since melanin is a protective pigment in skin, it blocks UV rays from damaging DNA, and protects against skin cancer

Actionable Locoregional Failures (LRFs) after Therapy of Localized Esophageal Carcinoma (LEC): Surveillance Strategies and their Benefits

Early results suggest that up to 80 percent of mitochondria exposed to AP39 are preserved by the gas

THE ANTI-CELL DEATH ROLE OF GSH The anti-cell death functions of GSH are mediated through coordinated control of oxidative stress, redox-sensitive signaling, and cysteine-based protein modification, thereby setting the threshold for commitment to regulated cell death

Multiple clinical trials of combining anti-angiogenic therapy and immune checkpoint inhibitors are underway (Zirlik and Duyster, 2018)